Carl Wild
Impact in
- Virology top 0.1%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Virology 26
- HIV Research and Treatment 26
-
- HIV/AIDS drug development and treatment 23
- HIV/AIDS Research and Interventions 3
- Co-authors
- Thomas J. Matthews (5 shared papers)Charlene McDanal (3 shared papers)D C Shugars (2 shared papers)Carol D. Weiss (3 shared papers)Yongkai Weng (2 shared papers)Rika A. Furuta (2 shared papers)Terrence G. Oas (2 shared papers)Dani P. Bolognesi (2 shared papers)
- Journals
- Journal of Virology (9 papers)Proceedings of the National Academy of Sciences (4 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of Medicinal Chemistry (2 papers)Virology (2 papers)
- Partner nations
- United StatesIndiaChina
In The Last Decade
Carl Wild
36 papers receiving 3.7k citations
Carl Wild's Hit Papers
Peers
Comparison fields: 5 of 94
- Virology 2.6k
- Infectious Diseases 1.8k
- Immunology 887
- Hepatology 208
- Epidemiology 706
Countries citing papers authored by Carl Wild
This map shows the geographic impact of Carl Wild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Wild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Wild more than expected).
Fields of papers citing papers by Carl Wild
This network shows the impact of papers produced by Carl Wild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Wild. The network helps show where Carl Wild may publish in the future.
Co-authors
The 25 scholars most cited alongside Carl Wild, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Hit paper breakdown → | 1994 | 804 |
| 2 | 1998 | 443 | |
| 3 | 1992 | 420 | |
| 4 | 2003 | 337 | |
| 5 | 2001 | 186 | |
| 6 | 2004 | 184 | |
| 7 | 1994 | 180 | |
| 8 | 2001 | 141 | |
| 9 | 2001 | 127 | |
| 10 | 2006 | 99 | |
| 11 | 1991 | 72 | |
| 12 | 2003 | 62 | |
| 13 | 2006 | 60 | |
| 14 | 2006 | 56 | |
| 15 | 1994 | 54 | |
| 16 | 2001 | 49 | |
| 17 | 2004 | 49 | |
| 18 | 1996 | 48 | |
| 19 | 2015 | 43 | |
| 20 | 2003 | 42 |
About Carl Wild
Carl Wild is a scholar working on Virology, Infectious Diseases, Molecular Biology, Organic Chemistry and Epidemiology, having authored 37 papers that have together received 3.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (26 papers), HIV/AIDS drug development and treatment (23 papers), Carbohydrate Chemistry and Synthesis (7 papers), Herpesvirus Infections and Treatments (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers), HIV/AIDS Research and Interventions (3 papers) and Phytochemical compounds biological activities (2 papers). The work is most often cited by research in Virology (2.6k citations), Infectious Diseases (1.8k citations), Immunology (887 citations), Hepatology (208 citations) and Epidemiology (706 citations). Carl Wild has collaborated with scholars based in United States, India and China. Frequent co-authors include Thomas J. Matthews, Charlene McDanal, D C Shugars, Carol D. Weiss, Yongkai Weng, Rika A. Furuta, Terrence G. Oas, Dani P. Bolognesi, Graham P. Allaway and Karl Salzwedel. Their work appears in journals such as Journal of Virology, Proceedings of the National Academy of Sciences, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry and Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.